Home › Survey: Aubagio (Teriflunomide) Trails Gilenya (Fingolimod) for Multiple Sclerosis Treatment
 

Keywords :   


Survey: Aubagio (Teriflunomide) Trails Gilenya (Fingolimod) for Multiple Sclerosis Treatment

2013-06-01 21:06:44| Biotech - Topix.net

BioTrends Research Group, a research and advisory firm located in Exton, Pennsylvania, finds that more than half of surveyed neurologists have prescribed Aubagio - the second oral disease-modifying agent marketed for the treatment of multiple sclerosis - to at least one of their MS patients at 6 months post-launch. While this represents a ... (more)

Tags: multiple treatment survey trails

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Weekly Recap: Rockline Wins WOW Innovation Award, Hospeco Purchases Nuance Solutions & More
30.06Eastern North Pacific Tropical Weather Outlook
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Public Advisory Number 7A
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Eastern North Pacific Tropical Weather Outlook
30.06Atlantic Tropical Weather Outlook
30.06Hurricane Beryl Forecast Discussion Number 7
More »